过去一年中添加的文章,按日期排序

Enzyme replacement therapy in Fabry cardiomyopathy: an incomplete treatment

K Nicholls - Heart, 2024 - heart.bmj.com
18 天前 - Enzyme replacement therapy (ERT) emerged as the first specific therapy for Fabry
disease at the dawn of this century, when life expectancy for untreated Fabry disease was …

Neurologic Care for Transgender and Gender-Diverse People: A Review of Current Evidence and Clinical Implications

G Zeigler, CA Harrington, N Rosendale… - Neurology: Clinical …, 2024 - AAN Enterprises
20 天前 - … at risk of cerebrovascular diseases. Androgen-lowering agents can allow for
therapeutic effects with lower doses of estrogen when estrogen causes neurologic adverse events. …

Cerebrovascular Endothelial Dysfunction: Role of BACE1

ZS Katusic, L d'Uscio, T He - Arteriosclerosis, Thrombosis, and …, 2024 - Am Heart Assoc
25 天前 - … in the cerebrovascular endothelium impairs key homeostatic functions of the brain
blood vessels. This concept has important therapeutic implications. … cerebrovascular function. …

The role of angiotensin II type 1 receptor pathway in cerebral ischemia‒reperfusion injury: Implications for the neuroprotective effect of ARBs

S Huang, M Zhang - Neuroprotection, 2024 - Wiley Online Library
34 天前 - … factor that impacts the prognosis of recanalization therapy for acute ischemic stroke
(AIS… , apoptosis, and it affects cerebrovascular autoregulation and the maintenance of blood…

AB1096 PREVALENCE, CHARACTERISTICS AND OUTCOMES OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS IN MOROCCO: A CASE SERIES …

H Hanani, W Ammouri, L Kherroubi, S Belkhettab… - 2024 - ard.bmj.com
38 天前 - … Conclusion: The heterogeneity of NPSLE and its therapeutic implications
requires to exclude all differential diagnoses and a systematic APS assessment. High rates of …

The vascular contribution of apolipoprotein E to Alzheimer's disease

F Chen, J Zhao, F Meng, F He, J Ni, Y Fu - Brain, 2024 - academic.oup.com
54 天前 - … the pathogenesis of Alzheimer’s disease. We present a … therapeutics targeting the
16 cerebrovascular pathology associated with apolipoprotein E and explore their implications

… (Qurtum/Safflower), Their Traditional Knowledge, Chemical Derivatives, and Potential Benefits in the Management of Neurodegenerative Diseases in the Elderly

N Anwar, NZ Ahmed, AP Ansari… - … Diseases - taylorfrancis.com
61 天前 - … protective effects in neurodegenerative diseases (Aleem et … of cardiovascular and
cerebrovascular diseases. The whole … of novel therapeutics for neurodegenerative diseases. …

[HTML][HTML] Obstructive sleep apnea hypopnea syndrome and vascular lesions: An update on what we currently know

Z Mao, P Zheng, X Zhu, L Wang, F Zhang, H Liu, H Li… - Sleep Medicine, 2024 - Elsevier
62 天前 - … and cerebrovascular conditions, … diseases and subsequently describes the
existing evidence on vascular lesions induced by OSAHS in the cardiovascular, cerebrovascular, …

Neurofilaments as biomarkers in neurological disorders—towards clinical application

M Khalil, CE Teunissen, S Lehmann, M Otto… - Nature Reviews …, 2024 - nature.com
87 天前 - … sclerosis, Alzheimer disease, frontotemporal dementia, amyotrophic lateral sclerosis,
stroke and cerebrovascular disease, traumatic brain injury, and Parkinson disease. We …

Aspirin treatment for unruptured intracranial aneurysms: Focusing on its anti-inflammatory role

Y Feng, H Zhang, S Dai, X Li - Heliyon, 2024 - cell.com
96 天前 - Intracranial aneurysms (IAs), as a common cerebrovascular disease, claims a worldwide
morbidity rate of 3.2%. Inflammation, pivotal in the pathogenesis of IAs, influences their …